SM
Sabby Management Portfolio holdings
AUM
$13M
1-Year Return
26.95%
This Quarter Return
+2.03%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$111M
AUM Growth
+$33.5M
(+44%)
Cap. Flow
+$32.8M
Cap. Flow
% of AUM
29.64%
Top 10 Holdings %
Top 10 Hldgs %
51.67%
Holding
118
New
40
Increased
16
Reduced
10
Closed
22
Top Buys
| 1 |
SRNE
Sorrento Therapeutics, Inc.
SRNE
|
$6.76M |
| 2 |
AstraZeneca
AZN
|
$6.39M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
$4.25M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$4.12M |
| 5 |
Rockwell Medical
RMTI
|
$3.85M |
Top Sells
| 1 |
Biogen
BIIB
|
$16.8M |
| 2 |
Health Care Select Sector SPDR Fund
XLV
|
$10.7M |
| 3 |
Xeris Biopharma Holdings
XERS
|
$2.89M |
| 4 |
PLLL
Piedmont Lithium Limited American Depositary Receipts
PLLL
|
$2.88M |
| 5 |
ALNA
Allena Pharmaceuticals, Inc. Common Stock
ALNA
|
$2.42M |
Sector Composition
| 1 | Healthcare | 73.93% |
| 2 | Technology | 3.83% |
| 3 | Industrials | 3.27% |
| 4 | Communication Services | 2.49% |
| 5 | Consumer Staples | 0.7% |
